|Articles|April 27, 2023
Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke (INTERPHEX 2023)
James Rorke, vice-president, operations, Steriline North America, discusses the benefits of automation in fill/finish operations.
Advertisement
James Rorke, vice-president, operations, Steriline North America, discusses the advantages of automation in fill/finish, particulary for low volume, high quaility products such as cell and gene therapies, for which minimizing product loss is crucial.
For more INTERPHEX 2023 video content, check
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
2
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
3
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
4
Danish Biotechs Attracting Investor Attention
5